KRL74
KRL74 is a cyclic peptide inhibitor for interaction between the p6 domain of the HIV Gag protein and the UEV domain of the human TSG101 protein (p6/UEV) with an IC50 of 5.44 μM and a Kd of 11.9 μM. KRL74 inhibits the budding process of HIV from host cells with an IC50 of 2 μM in virus-like particle (VLP) budding assay[1].
Product Specifications
CAS Number
2423969-43-9
UNSPSC
12352209
Target
HIV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
O=C([C@@H](NC([C@](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC1=O)C)=O)C(C)C)=O)CO)=O)=O)CC2=CNC3=CC=CC=C23)=O)([H])[C@@H](C)CC)=O)CC4=CC=C(C=C4)Cl)N[C@H]1CC5=CNC6=CC=CC=C56
Molecular Formula
C50H61ClN10O9
Molecular Weight
981.53
References & Citations
[1]Lennard KR, et al., Development of a Cyclic Peptide Inhibitor of the p6/UEV Protein-Protein Interaction. ACS Chem Biol. 2019 Sep 20;14 (9) :1874-1878.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400745-100 1x 100 µL
CD45 / LCA (2B11 + PD7/26), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741820-500 1x 500 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042344-100 1x 100 µL
CD44v9 (Marker of Tumor Metastasis) (CD44v9/2344R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941409-100 1x 100 µL
MART-1 / Melan-A / MLANA (Melanoma Marker) (MLANA/1409R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402993-500 1x 500 µL
Renal Cell Carcinoma (Carbonic Anhydrase IX) (CA9/2993R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details